-
The Phase II clinical trial of Pfizer Ponsegromab in the treatment of cancer cachexia has reached its primary endpoint
On September 22, Pfizer announced on its official WeChat account that its phase II clinical trial of the monoclonal antibody Ponsegromab targeting growth differentiation factor-15 (GDF-15) had reache ... -
How far can the US stock market continue to rise after the expected end point of the Federal Reserve's interest rate hike is digested?
Boosted by the expected end point of the Federal Reserve's interest rate hike cycle, which has been strengthened by a pullback in inflation and a cooling economy, the US stock market has risen for th ...